Average Co-Inventor Count = 6.30
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aeterna Zentaris Gmbh (12 from 36 patents)
2. Zentaris Gmbh (2 from 22 patents)
3. Zentaris Ag (2 from 20 patents)
16 patents:
1. 8937068 - Pyridopyrazine derivatives and their use
2. 8912189 - Pyridopyrazine derivatives and their use
3. 8791118 - Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors
4. 8604196 - Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thiourea
5. 8541462 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
6. 8536332 - Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines
7. 8507486 - Pyridopyrazine derivatives, process of manufacturing and uses thereof
8. 8470776 - Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
9. 8461178 - Naphthyridine derivatives and the use thereof as kinase inhibitors
10. 8394801 - Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
11. 8217042 - Pyridopyrazines and their use as modulators of kinases
12. 8202883 - Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases
13. 8148546 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
14. 7741277 - Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
15. 7378522 - Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone